Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals Incorporated ... JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

2-Year U.S. Treasury Note Continuous Contract $103.535 0.047 0.05% 5-Year U.S. Treasury Note Continuous Contract $108.070 0.148 0.14% 10-Year U.S. Treasury Note Continuous Contract $111.297 0.297 ...

After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...

Acer Aspire VX-15 is a Windows 10 Home laptop with a 15.60-inch display that has a resolution of 1920x1080 pixels. It is powered by a Core i7 processor and it comes with 8GB of RAM. The Acer Aspire VX ...